Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23687260 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)
Condition: Rheumatoid Arthritis
Intervention: Drug: Infliximab

Indicates status has not been verified in more than two years